Výsledky vyhledávání - "Melanie Weigel"

Akademický článek

First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.

Autor: Norbert Pfeiffer, Bogomil Voykov, Giulia Renieri, Katharina Bell, Paul Richter, Melanie Weigel, Hagen Thieme, Barbara Wilhelm, Katrin Lorenz, Martin Feindor, Katja Wosikowski, Michel Janicot, Daniela Päckert, Regina Römmich, Carola Mala, Petra Fettes, Eugen Leo

Publikováno v: PLoS ONE, Vol 12, Iss 11, p e0188899 (2017)

To evaluate the safety and tolerability of intravitreal ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in patients with primary open angle glaucoma (POAG) undergoing trabeculectomy (TE; glauc

Externí odkaz: https://doaj.org/article/5b269b6322544aeb927497877deed479

Zobrazit plný text záznamu

Telemetric Measurement of Intraocular Pressure via an Implantable Pressure Sensor—12-Month Results from the ARGOS-02 Trial

Autor: Lars Choritz, Kaweh Mansouri, Jacqueline van den Bosch, Melanie Weigel, H. Burkhard Dick, Markus Wagner, Hagen Thieme, Florian Rüfer, Peter Szurmann, Wolfram Wehner, Martin Spitzer, Lutz Hesse, Anselm Jünemann, Niklas Plange, Stefanie Schmickler, Burkhard Dick, Kaymak Hakan

Publikováno v: American Journal of Ophthalmology
American journal of ophthalmology 209, 187-196 (2020). doi:10.1016/j.ajo.2019.09.011

American journal of ophthalmology 209, 187-196 (2020). doi:10.1016/j.ajo.2019.09.011
Published by Elsevier Science, New York, NY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2d03726652aec4658a7961e34f6549

Zobrazit plný text záznamu

Autor: Martin Feindor, Bogomil Voykov, Melanie Weigel, Katharina Bell, Hagen Thieme, Paul Richter, Katrin Lorenz, Regina Römmich, Michel Janicot, Barbara Wilhelm, Giulia Renieri, Katja Wosikowski, Petra Fettes, Daniela Päckert, Eugen Leo, Carola Mala, Norbert Pfeiffer

Publikováno v: PLoS ONE, Vol 12, Iss 11, p e0188899 (2017)
PLoS ONE

PURPOSE To evaluate the safety and tolerability of intravitreal ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in patients with primary open angle glaucoma (POAG) undergoing trabeculectomy (T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07fe8f3eb7a4c6d2b878716b47260b10
http://europepmc.org/articles/PMC5708654?pdf=render

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání